Jean‐Yves Le Heuzey

Author

Jean‐Yves Le Heuzey

Also Known As

Bettina Ammentorp, D Dietz, E Marijon, E. Marijon, Eiji Kusumi, Frédéric Casassus, Hein Heidbüchel, J Le Heuzey, J. Le Heuzey, JEAN‐YVES LE HEUZEY

162

Publications

15.6K

Citations

H-Index

Concepts

All Affiliations

Hôpital Européen Georges-Pompidou Université Paris Cité Inserm Hôpital Européen St George's, University of London

About

Jean‐Yves Le Heuzey is an author at Hôpital Européen Georges-Pompidou specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	34	3.6K
2	Public Health	19	25	3.1K
3	Health Sciences	1	1	41
4	Biomedical Engineering	1	1	67
5	Cardiothoracic Surgery	1	1	11

Jean‐Yves Le Heuzey

Publications

9.5K

Citations

H-Index

Page 1

	Year	Citations
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure Denis Roy, Mario Talajic, Stanley Nattel, New England Journal of Medicine	2008	1.6K
Atrial fibrillation management: a prospective survey in ESC Member Countries Robby Nieuwlaat, Alessandro Capucci, A. John Camm, European Heart Journal	2005	822
Sports-Related Sudden Death in the General Population Éloi Marijon, Muriel Tafflet, David S. Celermajer, Circulation	2011	528
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation Valentı́n Fuster, Lars Rydén, David S. Cannom, Journal of the American College of Cardiology ThrombosisCardiac AnaesthesiaAcc/aha/esc 2006Cardiovascular DiseasePatient Safety	2006	467
Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF) Paulus Kirchhof, Bettina Ammentorp, Harald Darius, EP Europace	2013	408
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran) L. Samüel Wann, Anne B. Curtis, Kenneth A. Ellenbogen, Heart Rhythm ThrombosisCardiovascular DiseasePatient SafetyCardiovascular PharmacologyPharmacotherapy	2011	398
A Short‐Term, Randomized, Double‐Blind, Parallel‐Group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study Jean‐Yves Le Heuzey, Gaetano Maria De Ferrari, David Radzik, Journal of Cardiovascular Electrophysiology	2010	385
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation Riccardo Cappato, Michael D. Ezekowitz, Allan L. Klein, European Heart Journal	2014	365
[Guidelines for the management of patients with atrial fibrillation. Executive summary]. Valentı́n Fuster, Lars E Rydén, David S Cannom, PubMed ThrombosisCardiovascular DiseasePatient SafetyCardiovascular PharmacologyAtrial Fibrillation	2006	359
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary Valentı́n Fuster, Lars Rydén, David S. Cannom, Circulation ThrombosisCardiac AnaesthesiaAcc/aha/esc 2006Cardiovascular DiseasePatient Safety	2006	346

Page 1